Cytodyn Inc (CYDY)

[dyates]

FDA Clears CytoDyn’s Phase 2 Randomized Trial to Treat Mild-to-Moderately Ill Coronavirus Patients with Leronlimab; Enrollment to Begin Immediately

https://finance.yahoo.com/news/fda-clears-cytodyn-phase-2-100010207.html


CytoDyn Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants

https://www.benzinga.com/pressreleases/20/03/g15703688/cytodyn-completes-non-dilutive-15-million-convertible-note-financing-with-conversion-rate-at-4-50-